ArticleFrontiers in pharmacology2025

Pan-cancer profiling of FZD2 as a prognostic biomarker: integrative multi-omics analysis with experimental validation and functional characterization in gastric cancer.

Sijiang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.